Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement.

Simon MatooriJohannes M FroehlichStefan BreitensteinViktoria PozdniakovaCarolin ReischauerOrpheus KolokythasDow-Mu KohAndreas Gutzeit

Published in: European radiology (2019)

• A multiple regression analysis identified independent confounding variables of hepatobiliary-phase gadoxetate liver enhancement. • High bilirubin, low albumin, or advanced age was associated with low enhancement. • Diagnostic evaluation might be hampered in these patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
case report
patient reported outcomes
patient reported